Literature DB >> 8551226

Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts.

P Merville1, J Déchanet, A Desmoulière, I Durand, O de Bouteiller, P Garrone, J Banchereau, Y J Liu.   

Abstract

Plasma cells represent the final stage of B lymphocyte differentiation. Most plasma cells in secondary lymphoid tissues live for a few days, whereas those in the lamina propria of mucosa and in bone marrow live for several weeks. To investigate the regulation of human plasma cell survival, plasma cells were isolated from tonsils according to high CD38 and low CD20 expression. Tonsillar plasma cells express CD9, CD19, CD24, CD37, CD40, CD74, and HLA-DR, but not CD10, HLA-DQ, CD28, CD56, and Fas/CD95. Although plasma cells express intracytoplasmic Bcl-2, they undergo swift apoptosis in vitro and do not respond to CD40 triggering. Bone marrow fibroblasts and rheumatoid synoviocytes, however, prevented plasma cells from undergoing apoptosis in a contact-dependent fashion. These data indicate that fibroblasts may form a microenvironment favorable for plasma cell survival under normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551226      PMCID: PMC2192413          DOI: 10.1084/jem.183.1.227

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Genes for normal and diseased mental states.

Authors:  F Ashall
Journal:  Trends Genet       Date:  1994-02       Impact factor: 11.639

2.  Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.

Authors:  K C Anderson; M P Bates; B L Slaughenhoupt; G S Pinkus; S F Schlossman; L M Nadler
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

3.  Phenotypic difference of normal plasma cells from mature myeloma cells.

Authors:  H Harada; M M Kawano; N Huang; Y Harada; K Iwato; O Tanabe; H Tanaka; A Sakai; H Asaoku; A Kuramoto
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

4.  Expression of cell surface markers after human B lymphocyte activation.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  In vivo obtained antigen presented by germinal center B cells to T cells in vitro.

Authors:  M H Kosco; A K Szakal; J G Tew
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

6.  Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.

Authors:  C Lagresle; C Bella; P T Daniel; P H Krammer; T Defrance
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

Review 7.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

8.  B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

Authors:  L M Nadler; K C Anderson; G Marti; M Bates; E Park; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

9.  Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells.

Authors:  S Scott; F Pandolfi; J T Kurnick
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  27 in total

1.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Authors:  J A Coronella; P Telleman; T D Truong; F Ylera; R P Junghans
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells.

Authors:  F Medina; C Segundo; A Campos-Caro; I Salcedo; A García-Poley; J A Brieva
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 4.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

5.  Transendothelial migration confers a survival advantage to activated T lymphocytes: role of LFA-1/ICAM-1 interactions.

Authors:  N J Borthwick; A A Akbar; C Buckley; D Pilling; M Salmon; A P Jewell; K L Yong
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

6.  Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection.

Authors:  Anouk Caraux; Martin Perez-Andres; Marion Larroque; Guilhem Requirand; Zhao-Yang Lu; Tarik Kanouni; Jean F Rossi; Alberto Orfao; Bernard Klein
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

7.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells.

Authors:  Jacob M van Laar; Marc Melchers; Y K Onno Teng; Boris van der Zouwen; Rozbeh Mohammadi; Randy Fischer; Leonid Margolis; Wendy Fitzgerald; Jean-Charles Grivel; Ferdinand C Breedveld; Peter E Lipsky; Amrie C Grammer
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

9.  Telomere lengthening and telomerase activation during human B cell differentiation.

Authors:  N P Weng; L Granger; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 10.  Global gene expression profiling in the study of multiple myeloma.

Authors:  John D Shaughnessy
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.